Federal health advisers are meeting to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective.
Infants who do not receive intramuscular vitamin K prophylaxis at birth have higher odds of bleeding episodes and intracranial hemorrhage during the first 6 months of life.
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results